The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BLOCK LISTING SIX MONTHLY RETURN

15 Sep 2017 14:00

RNS Number : 9199Q
Dechra Pharmaceuticals PLC
15 September 2017
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Long-Term Incentive Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

21,507

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

174,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

195,507

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

8,184

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

25,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

6,077

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

27,107

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

65,972

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

55,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

23,254

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

97,718

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

11,811

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

75,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

70,378

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

16,433

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUQABUPMGPA
Date   Source Headline
28th Nov 202311:41 amRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Nov 202310:39 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
28th Nov 202310:06 amRNSForm 8.5 (EPT/NON-RI)
28th Nov 202310:03 amRNSForm 8.5 (EPT/RI)
28th Nov 20239:04 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
28th Nov 20239:01 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
28th Nov 20237:00 amRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 20232:54 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
27th Nov 20231:27 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
27th Nov 20231:26 pmPRNForm 8.3 - Dechra Pharmaceuticals Plc
27th Nov 202312:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 202311:54 amRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 202311:10 amRNSHolding(s) in Company
27th Nov 202310:50 amRNSRemuneration Statement re Tony Griffin
27th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI)
27th Nov 202310:24 amRNSForm 8.5 (EPT/RI)
27th Nov 202310:01 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
27th Nov 20239:14 amRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Nov 20238:43 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
27th Nov 20238:17 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
27th Nov 20237:00 amRNSDirectorate Change
24th Nov 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
24th Nov 20232:47 pmRNSHolding(s) in Company
24th Nov 20232:43 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
24th Nov 20232:13 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
24th Nov 20231:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
24th Nov 20231:17 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
24th Nov 202312:11 pmRNSHolding(s) in Company
24th Nov 202311:38 amRNSForm 8.3 - Dechra Pharmaceuticals plc
24th Nov 202311:19 amRNSForm 8.3 - Dechra Pharmaceuticals plc
24th Nov 202311:10 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
24th Nov 202310:23 amRNSForm 8.5 (EPT/RI)
24th Nov 202310:21 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20239:34 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
24th Nov 20237:58 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
23rd Nov 20233:31 pmRNSForm 8.3 - Dechra Pharmaceuticals plc Amendment
23rd Nov 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
23rd Nov 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
23rd Nov 20233:20 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC
23rd Nov 20233:09 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
23rd Nov 20232:47 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
23rd Nov 20231:17 pmRNSHolding(s) in Company
23rd Nov 20231:16 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC
23rd Nov 202312:35 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
23rd Nov 202311:54 amRNSForm 8.3 - Dechra Pharmaceuticals plc
23rd Nov 202310:22 amRNSForm 8.3 - Dechra Pharmaceuticals plc
23rd Nov 202310:21 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
23rd Nov 202310:05 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.